MIRA Pharmaceuticals, Inc. Common Stock Strategic Asset Allocation Index
MIRA Pharmaceuticals, Inc. Common Stock strategic asset allocation index. MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a Strategic Asset Allocation Index of 11.1% as of June 2023. Strategic assets (PP&E of $132.33K plus long-term investments of $-) total $132.33K, measured against net assets of $1.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is MIRA Pharmaceuticals, Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
MIRA Pharmaceuticals, Inc. Common Stock Strategic Asset Allocation Index by Year (None–None)
MIRA Pharmaceuticals, Inc. Common Stock strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for MIRA Pharmaceuticals, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see MIRA Pharmaceuticals, Inc. Common Stock stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|